These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 23474853)
1. A sex- and region-specific role of Akt1 in the modulation of methamphetamine-induced hyperlocomotion and striatal neuronal activity: implications in schizophrenia and methamphetamine-induced psychosis. Chen YW; Kao HY; Min MY; Lai WS Schizophr Bull; 2014 Mar; 40(2):388-98. PubMed ID: 23474853 [TBL] [Abstract][Full Text] [Related]
2. Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways. Beauvais G; Atwell K; Jayanthi S; Ladenheim B; Cadet JL PLoS One; 2011; 6(12):e28946. PubMed ID: 22174933 [TBL] [Abstract][Full Text] [Related]
4. Behavioral phenotyping of v-akt murine thymoma viral oncogene homolog 1-deficient mice reveals a sex-specific prepulse inhibition deficit in females that can be partially alleviated by glycogen synthase kinase-3 inhibitors but not by antipsychotics. Chen YW; Lai WS Neuroscience; 2011 Feb; 174():178-89. PubMed ID: 20888398 [TBL] [Abstract][Full Text] [Related]
5. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice. Itzhak Y; Martin JL; Ali SF Synapse; 1999 Dec; 34(4):305-12. PubMed ID: 10529724 [TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma activation relieves expression of behavioral sensitization to methamphetamine in mice. Maeda T; Kiguchi N; Fukazawa Y; Yamamoto A; Ozaki M; Kishioka S Neuropsychopharmacology; 2007 May; 32(5):1133-40. PubMed ID: 17019405 [TBL] [Abstract][Full Text] [Related]
7. Methamphetamine-induced changes in the striatal dopamine pathway in μ-opioid receptor knockout mice. Park SW; Shen X; Tien LT; Roman R; Ma T J Biomed Sci; 2011 Nov; 18(1):83. PubMed ID: 22074218 [TBL] [Abstract][Full Text] [Related]
8. Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice. Bosse KE; Charlton JL; Susick LL; Newman B; Eagle AL; Mathews TA; Perrine SA; Conti AC J Neurochem; 2015 Dec; 135(6):1218-31. PubMed ID: 26146906 [TBL] [Abstract][Full Text] [Related]
9. New Repeat Polymorphism in the Shumay E; Wiers CE; Shokri-Kojori E; Kim SW; Hodgkinson CA; Sun H; Tomasi D; Wong CT; Weinberger DR; Wang GJ; Fowler JS; Volkow ND J Neurosci; 2017 May; 37(19):4982-4991. PubMed ID: 28416594 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of environment-induced changes in body temperature on modafinil's actions against methamphetamine-induced striatal toxicity in mice. Raineri M; González B; Rivero-Echeto C; Muñiz JA; Gutiérrez ML; Ghanem CI; Cadet JL; García-Rill E; Urbano FJ; Bisagno V Neurotox Res; 2015 Jan; 27(1):71-83. PubMed ID: 25261212 [TBL] [Abstract][Full Text] [Related]
11. Brain Renin-Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity. Jiang L; Zhu R; Bu Q; Li Y; Shao X; Gu H; Kong J; Luo L; Long H; Guo W; Tian J; Zhao Y; Cen X Neurotherapeutics; 2018 Apr; 15(2):500-510. PubMed ID: 29464572 [TBL] [Abstract][Full Text] [Related]
12. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization. Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235 [TBL] [Abstract][Full Text] [Related]
13. D1R/PP2A/p-CaMKIIα signaling in the caudate putamen is involved in acute methamphetamine-induced hyperlocomotion. Shang Q; Xiao J; Gao B; Liang M; Wang J; Qian H; Xi Z; Li T; Liu X Neurosci Lett; 2021 Aug; 760():136102. PubMed ID: 34237414 [TBL] [Abstract][Full Text] [Related]
14. Role of neurokinin-1 and dopamine receptors on the striatal methamphetamine-induced proliferation of new cells in mice. Tulloch I; Ghazaryan N; Mexhitaj I; Ordonez D; Angulo JA Brain Res; 2011 Jul; 1399():33-9. PubMed ID: 21652034 [TBL] [Abstract][Full Text] [Related]
15. The effects of single-dose injections of modafinil and methamphetamine on epigenetic and functional markers in the mouse medial prefrontal cortex: potential role of dopamine receptors. González B; Torres OV; Jayanthi S; Gomez N; Sosa MH; Bernardi A; Urbano FJ; García-Rill E; Cadet JL; Bisagno V Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():222-234. PubMed ID: 30056065 [TBL] [Abstract][Full Text] [Related]
16. Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization. Itzhak Y; Martin JL; Black MD; Ali SF Neuropharmacology; 1998 Jun; 37(6):781-91. PubMed ID: 9707292 [TBL] [Abstract][Full Text] [Related]
17. Estrogen and progesterone distinctively modulate methamphetamine-induced dopamine and serotonin depletions in C57BL/6J mice. Yu L; Liao PC J Neural Transm (Vienna); 2000; 107(10):1139-47. PubMed ID: 11129103 [TBL] [Abstract][Full Text] [Related]
18. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. Itzhak Y; Gandia C; Huang PL; Ali SF J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865 [TBL] [Abstract][Full Text] [Related]
19. Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release. Ago Y; Tanaka T; Kita Y; Tokumoto H; Takuma K; Matsuda T Neuropharmacology; 2012 Mar; 62(4):1634-9. PubMed ID: 22001792 [TBL] [Abstract][Full Text] [Related]
20. Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice. Zhu JP; Xu W; Angulo JA Neuroscience; 2006 Jun; 140(2):607-22. PubMed ID: 16650608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]